Skip to content

The effect of stretching the transverse carpal ligament using curpal® on clinical symptoms and various neurophysiological parameters in carpal tunnel syndrome (CTS) – a prospective, randomised trial

The effect of stretching the transverse carpal ligament using curpal® on clinical symptoms and various neurophysiological parameters in carpal tunnel syndrome (CTS) – a prospective, randomised trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020570
Enrollment
76
Registered
2020-12-21
Start date
2021-03-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G56.0

Interventions

Group 1: curpal® treatment group Group 2: surgery group

Sponsors

Universitätsklinikum Freiburg Kliniken für Neurologie und Neurochirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Minimum age 18 years. Clinically and electrophysiologically proven CTS Already unsuccessful therapy with NSAIDs, hand splints and other conservative therapies (physiotherapy, occupational therapy) over a minimum period of 4 weeks

Exclusion criteria

Exclusion criteria: Parallel presence of polyneuropathy Traumatic injuries in the wrist area Pre-surgery in the wrist and nerve area Arthritis in the hand area Pregnancy Ongoing legal proceedings Contact allergies to the materials used in the stretching devices Severe secondary diseases (tumor diseases, severe organ impairment) Motor deficit beyond a fine motor disorder

Design outcomes

Primary

MeasureTime frame
Change in BCTSQ score after 8 weeks. The change (pre-post) in the BCTSQ score after 8 weeks is compared between the groups using the Wilcoxon-Mann-Whitney test. The two-sided significance level is set at alpha = 0.05.

Secondary

MeasureTime frame
Change in BCTSQ score after 6 months. Change in SF-8 scores and electrophysiological and sonographic parameters after 8 weeks and 6 months. The analyses of the secondary endpoints are descriptive.

Countries

Germany

Contacts

Public ContactChristoph Scholz und Herr Dr. Johann Lambeck

Universitätsklinikum Freiburg Kliniken für Neurologie und Neurochirurgie

christoph.scholz@uniklinik-freiburg.de0761-270-50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026